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I read with great interest the systematic review by Horsely et al.1 This study deploys a robust 
and transparent methodology to highlight the scale of reporting weaknesses within health 
education research. As a scholar who works as an Editor for both Cochrane and the Best 
Evidence Medical Education Collaborative (BEME),2 these findings do not surprise me. When 
considering clinical and educational research as part of systematic reviews, such weaknesses 
are frustratingly homogenous.  The author’s proposal to mirror shifts within Cochrane to 
judge quality of health education trials in other ways than simple checklists is one I 
wholeheartedly support. This is already reflected in risk of bias systems proposed as part of 
current protocols for systematic review within BEME.3 However, I would maintain that if the 
focus is shifted from secondary review to primary researchers, the use of CONSORT4 
guidance to support writing of manuscripts would cover most items considered within such 
risk of bias tools and significantly enhance reporting.  
 
An area that such novel risk of bias tools would fail to consider is related to reporting of 
educational interventions themselves. Within the context of pharmacological trials, there is 
a clearly understood interventional agent. As such, replication and dissemination of findings 
is not impacted by understanding the agent itself, rather how it was used and its 
effectiveness. Primary educational interventions are often novel, produced or adapted 
specifically for the study being reported and commonly poorly reported. This is a key area 
where study reports may vary in quality. Considering specific learning outcomes, 
underpinning theoretical frameworks and pedagogy are key to ensure interventions can be 
judged on their educational quality. This is a completely different issue to trial 
methodological quality, with no reason the two elements have to be in any way correlated.  
 
Poor reporting of non-pharmacological interventions is just as commonly seen in clinical 
medicine trials, with calls to adapt and extend the CONSORT statement5. In following the 
author’s suggestion to adopt Cochrane style risk of bias systems to judge quality, I would 
therefore propose that similar work is needed to extend such systems in the education 
context. They must consider the substantial variations that can exist in reporting of primary 
intervention as a potential source of bias and agree how to judge this. Only then can a risk 
of bias tool consider the quality of health education trials in a holistic and field specific 
manner. 
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